Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells-Reference-Cited by-同舟云学术

Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells

Published:2024-04-01 Issue:4 Volume:44 Page:178-189
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Tezcanli Kaymaz Burcin¹^ORCID,Gumus Nurcan²,Celik Besne¹,Alcitepe İlayda¹,Biray Avci Cigir¹,Aktan Cagdas³⁴

Affiliation:

1. Department of Medical Biology, Ege University Medical School, Izmir, Turkiye.

2. Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.

3. Department of Medical Biology, Beykent University Medical School, Istanbul, Turkiye.

4. Department of Medical Biology, Bandirma Onyedi Eylul University Medical School, Balikesir, Turkiye.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/jir.2023.0170

Reference65 articles.

1. TNF-α-Induced Bone Marrow Stromal Progenitor Alterations Enhance Leukemic Stem Cell Growth and Treatment Resistance Via Increased CXCL1-CXCR2 Signaling

2. Increased IFN-? synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia

3. Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia

4. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

5. Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy;Genes & Genomics;2024-08-10